CV (STOCKS)
CapsoVision, Inc. Common Stock
$4.830000
+0.140000 (+2.99%)
Prev close: $4.690000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Kang-Huai Wang
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $226.25M
- Employees
- —
- P/E (TTM)
- —
- P/B (TTM)
- 10.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.17 | $-0.13 | -0.0412 | -31.99% |
|
Jun 2025 (Q2)
|
$-2.02 | $-0.11 | -1.9067 | -1,682.88% |
Financial Statements
| Revenues | $358.89M |
| Benefits Costs and Expenses | $347.29M |
| Costs And Expenses | $341.72M |
| Nonoperating Income/Loss | $2.97M |
| Operating Expenses | $341.72M |
| Operating Income/Loss | $17.17M |
| Income/Loss Before Equity Method Investments | -$15.99M |
| Income/Loss From Continuing Operations After Tax | $6.15M |
| Income/Loss From Continuing Operations Before Tax | $12.08M |
| Income/Loss From Equity Method Investments | $27.59M |
| Income Tax Expense/Benefit | $5.45M |
| Interest Expense, Operating | $13.99M |
| Net Income/Loss | $6.15M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $6.15M |
| Net Income/Loss Available To Common Stockholders, Basic | $5.88M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $276.00K |
| Preferred Stock Dividends And Other Adjustments | $276.00K |
| Basic Earnings Per Share | $0.43 |
| Diluted Earnings Per Share | $0.43 |
| Basic Average Shares | 13,542,313 |
| Diluted Average Shares | 13,651,402 |
| Assets | $774.63M |
| Current Assets | $100.98M |
| Inventory | $7.85M |
| Other Current Assets | $93.14M |
| Noncurrent Assets | $198.39M |
| Fixed Assets | $389.62M |
| Liabilities | $498.37M |
| Current Liabilities | $78.64M |
| Accounts Payable | $8.70M |
| Other Current Liabilities | $69.94M |
| Noncurrent Liabilities | $180.99M |
| Equity | $276.26M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $276.26M |
| Liabilities And Equity | $774.63M |
| Net Cash Flow From Operating Activities | $31.50M |
| Net Cash Flow From Operating Activities, Continuing | $31.50M |
| Net Cash Flow From Investing Activities | -$55.56M |
| Net Cash Flow From Investing Activities, Continuing | -$55.56M |
| Net Cash Flow From Financing Activities | $10.66M |
| Net Cash Flow From Financing Activities, Continuing | $10.66M |
| Net Cash Flow | -$13.41M |
| Net Cash Flow, Continuing | -$13.41M |
| Comprehensive Income/Loss | $6.07M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $6.07M |
| Other Comprehensive Income/Loss | $6.07M |
| Other Comprehensive Income/Loss Attributable To Parent | -$86.00K |